A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)
Hyeongsoo Kim, Young Soo Lee, Tae-Hoon Kim, Myung-Jin Cha, Jung Myung Lee, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Jae-Sun Uhm, Hyung Wook Park, Eue-Keun Choi, Jin-Bae Kim, Changsoo Kim, Jun Kim, Boyoung Joung
Korean J Intern Med. 2020;35(1):99-108.   Published online 2019 Apr 25     DOI: https://doi.org/10.3904/kjim.2017.415
Citations to this article as recorded by Crossref logo
Patient concern regarding bleeding side effects from oral anticoagulation therapy for atrial fibrillation: an analysis from the multicentre KiCS-AF registry
Ikuko Ueda, Shun Kohsaka, Nobuhiro Ikemura, Takehiro Kimura, Yoshinori Katsumata, Ryo Takemura, Masahiro Suzuki, Seiji Takatsuki, Daisuke Koide, Keiichi Fukuda
European Journal of Cardiovascular Nursing.2024; 23(4): 358.     CrossRef
Lessons derived from post authorisation safety studies (ETNA-AF and XANTUS) on once daily direct oral anticoagulants for atrial fibrillation
Roberto Cemin, Riccardo Cappato
International Journal of Cardiology.2024; 398: 131618.     CrossRef
Comparison of warfarin, rivaroxaban, and dabigatran for effectiveness and safety in atrial fibrillation patients with different CHA2DS2-VASc scores: a retrospective cohort study
Yue Zhao, Hong Ren, Shiwei Xu
BMC Cardiovascular Disorders.2024;[Epub]     CrossRef
Comparison of the Treatment Persistence Among 4 Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A 5‐Year Retrospective Cohort Study
Tomohiro Aigami, Tomoyuki Ishigo, Ryo Takada, Toshiyuki Yano, Masayuki Koyama, Satoshi Katano, Satoshi Fujii, Masahide Fukudo
The Journal of Clinical Pharmacology.2023; 63(6): 654.     CrossRef
Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
MuHyung Heo, Dong Seop Jeong, Suryeun Chung, Kyoung Min Park, Seung Jung Park, Young Keun On
Journal of Chest Surgery.2023; 56(2): 90.     CrossRef
Anticoagulant Treatment Adherence and Persistence in German Patients with Atrial Fibrillation
Giuseppe Patti, Rosa Wang, Xiaocong Li Marston, Yu-Chen Yeh, Lisa Zimmermann, Xin Ye, Xin Gao, Bernd Brüggenjürgen
Cardiology and Therapy.2023; 12(2): 371.     CrossRef
Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
Tomasz Górnicki, Kacper Bułdyś, Dorota Zielińska, Mariusz Chabowski
Cancers.2023; 15(10): 2697.     CrossRef
Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios
Fabiana Lucà, Fabrizio Oliva, Maurizio Giuseppe Abrignani, Stefania Angela Di Fusco, Iris Parrini, Maria Laura Canale, Simona Giubilato, Stefano Cornara, Martina Nesti, Carmelo Massimiliano Rao, Andrea Pozzi, Giulio Binaghi, Alessandro Maloberti, Roberto
Journal of Clinical Medicine.2023; 12(18): 5955.     CrossRef
Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea
Myung-Yong Lee, Sola Han, Oh Young Bang, Young Keun On, Sung-Won Jang, Seongwook Han, Jaeyun Ryu, Yoo-Jung Park, Seongsik Kang, Hae Sun Suh, Young-Hoon Kim
Advances in Therapy.2022; 39(7): 3112.     CrossRef
Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis
Rokhsareh Ebrahimi, Abolfazl Barzegari, Reza Teimuri-Mofrad, Houman Kholafazad Kordasht, Mohammad Hasanzadeh, Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Abbas Afrasiabi Rad, Nasrin Shadjou, Mohammad-Reza Rashidi, Mohammad Reza Afshar Mogaddam, Ab
Biosensors.2022; 12(10): 773.     CrossRef
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation
Marco Vitolo, Deirdre A Lane, Giuseppe Boriani, Gregory Y H Lip
European Heart Journal - Cardiovascular Pharmacotherapy.2021; 7(FI1): f81.     CrossRef
Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study
Joris R de Groot, Thomas W Weiss, Peter Kelly, Pedro Monteiro, Jean Claude Deharo, Carlo de Asmundis, Esteban López-de-Sá, Johannes Waltenberger, Jan Steffel, Pierre Levy, Ameet Bakhai, Wolfgang Zierhut, Petra Laeis, Marius Constantin Manu, Paul-Egbert Re
European Heart Journal - Cardiovascular Pharmacotherapy.2021; 7(FI1): f30.     CrossRef
Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
Moutaz El Kadri, Ahmed Ghorab, Jean Joury, Mohamed Farghaly, Nancy Awad, Badarinath Chickballapur Ramachandrachar, Ashok Natarajan
Avicenna Journal of Medicine.2021; 11(02): 93.     CrossRef
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
Yutao Guo, Agnieszka Kotalczyk, Jacopo F Imberti, Yutang Wang, Gregory Y H Lip
European Heart Journal - Quality of Care and Clinical Outcomes.2021;[Epub]     CrossRef
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, Toon Wei Lim, Eue‐Keun Choi, Yi‐Hsin Chan, Yutao Guo, Charn Sriratanasathavorn, Seil Oh, Ken Okumura, Gregory Y. H. Lip
Journal of Arrhythmia.2021; 37(6): 1389.     CrossRef
The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry)
Seunghoon Cho, Jun Kim, Jin-Bae Kim, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Eue-Keun Choi, Young Soo Lee, Hyung Wook Park, Boyoung Joung
Scientific Reports.2020;[Epub]     CrossRef
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
Michele Magnocavallo, Antonio Bellasi, Marco Valerio Mariani, Maria Fusaro, Maura Ravera, Ernesto Paoletti, Biagio Di Iorio, Vincenzo Barbera, Domenico Giovanni Della Rocca, Roberto Palumbo, Paolo Severino, Carlo Lavalle, Luca Di Lullo
Journal of Clinical Medicine.2020; 10(1): 83.     CrossRef
How to maintain an adherence to oral anticoagulant in a patient with atrial fibrillation?
S. G. Kanorskii
Kardiologiia.2019; 59(11): 76.     CrossRef